How much does moboxetinib succinate capsules cost?

Mobositinib succinate capsule, a highly selective tyrosine kinase inhibitor, specifically targets and inhibits EGFR exon 20 insertion mutations. This innovative medicine brings a new treatment strategy to adult patients diagnosed with EGFRexon 20 insertion mutations in locally advanced or metastatic non-small cell lung cancer following a test approved by the U.S. Food and Drug Administration (FDA). It is particularly worth mentioning that these patients often experience further progression of their disease during or after receiving platinum-based chemotherapy. Mobosetinib capsules undoubtedly open a new treatment window for them.

Mobosetinib succinate capsules have been successfully marketed in China, but it has not yet been included in my country's medical insurance system. This means that for patients who need the drug, they are responsible for the full cost of the drug.

Take the current price on the market as an example.40mg*112The latest price of moboxetinib capsules is as high as 40,000 to 50,000 yuan. For many ordinary families, this is undoubtedly a huge financial burden.

But at the same time, overseas markets provide patients with more choices. For example, the Japanese original research version of 40mg*30 tablets of Mobotinib is priced at about 8,000 yuan, which is more affordable than the domestic version. In Bangladesh and Laos, patients can also purchase officially marketed generic drugs. The main ingredients of these drugs are basically the same as the original drugs, but the prices are more affordable. The latest price is only about 4,000 yuan.

Faced with such a large price difference, patients will naturally consider more economical options. But no matter which version of the drug a patient chooses, they must ensure the formality of its source, so as to ensure the quality and safety of the drug and thus ensure the effectiveness of the treatment.